Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0733 EUR
−38.22 M EUR
208.39 M EUR
389.70 M
About ALLIANCE PHARMA PLC
Sector
CEO
Nick Sedgwick
Headquarters
Chippenham
Website
Founded
2001
ISIN
GB0031030819
FIGI
BBG000QY2TM6
Alliance Pharma Plc is a holding company, which engages in the provision of acquisition, marketing, and distribution of healthcare and pharmaceutical products. It holds marketing rights to a range of healthcare brands and prescription medicines. The company was founded by John Dawson in 1996 and is headquartered in Chippenham, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Alliance Pharma PLC stocks are traded under the ticker DVL.
We've gathered analysts' opinions on Alliance Pharma PLC future price: according to them, DVL price has a max estimate of 1.02 EUR and a min estimate of 0.50 EUR. Watch DVL chart and read a more detailed Alliance Pharma PLC stock forecast: see what analysts think of Alliance Pharma PLC and suggest that you do with its stocks.
Yes, you can track Alliance Pharma PLC financials in yearly and quarterly reports right on TradingView.
Alliance Pharma PLC is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
Alliance Pharma PLC revenue for the last half-year amounts to 100.09 M EUR, despite the estimated figure of 100.09 M EUR. In the next half-year revenue is expected to reach 123.78 M EUR.
DVL net income for the last half-year is 5.50 M EUR, while the previous report showed −44.11 M EUR of net income which accounts for 112.48% change. Track more Alliance Pharma PLC financial stats to get the full picture.
As of Nov 14, 2024, the company has 292.00 employees. See our rating of the largest employees — is Alliance Pharma PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alliance Pharma PLC EBITDA is 60.44 M EUR, and current EBITDA margin is 24.90%. See more stats in Alliance Pharma PLC financial statements.
Like other stocks, DVL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alliance Pharma PLC stock right from TradingView charts — choose your broker and connect to your account.